These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33474654)

  • 1. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
    Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
    Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
    Wang Z; Stuckey DJ; Murdoch CE; Camelliti P; Lip GYH; Griffin M
    Cell Death Dis; 2018 Apr; 9(6):613. PubMed ID: 29795262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 and its role in pulmonary fibrosis.
    Olsen KC; Sapinoro RE; Kottmann RM; Kulkarni AA; Iismaa SE; Johnson GV; Thatcher TH; Phipps RP; Sime PJ
    Am J Respir Crit Care Med; 2011 Sep; 184(6):699-707. PubMed ID: 21700912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC8 inhibition ameliorates pulmonary fibrosis.
    Saito S; Zhuang Y; Suzuki T; Ota Y; Bateman ME; Alkhatib AL; Morris GF; Lasky JA
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L175-L186. PubMed ID: 30358439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent.
    Roach KM; Wulff H; Feghali-Bostwick C; Amrani Y; Bradding P
    Respir Res; 2014 Dec; 15(1):155. PubMed ID: 25476248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
    Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
    J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Matrix Cross-Linking Enhances Fibroblast Growth and Protects against Matrix Proteolysis in Lung Fibrosis.
    Philp CJ; Siebeke I; Clements D; Miller S; Habgood A; John AE; Navaratnam V; Hubbard RB; Jenkins G; Johnson SR
    Am J Respir Cell Mol Biol; 2018 May; 58(5):594-603. PubMed ID: 29053339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
    Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
    BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase-2 mediates calcium-regulated crosslinking of the Y-box 1 (YB-1) translation-regulatory protein in TGFβ1-activated myofibroblasts.
    Willis WL; Hariharan S; David JJ; Strauch AR
    J Cell Biochem; 2013 Dec; 114(12):2753-69. PubMed ID: 23804301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis.
    Mia MM; Bank RA
    J Cell Mol Med; 2015 Dec; 19(12):2780-92. PubMed ID: 26337045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.
    Amara N; Goven D; Prost F; Muloway R; Crestani B; Boczkowski J
    Thorax; 2010 Aug; 65(8):733-8. PubMed ID: 20685750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transglutaminase 2, a novel target for pulmonary fibrosis, by two small electrophilic molecules.
    Olsen KC; Epa AP; Kulkarni AA; Kottmann RM; McCarthy CE; Johnson GV; Thatcher TH; Phipps RP; Sime PJ
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):737-47. PubMed ID: 24175906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional relationship between transglutaminase 2 and transforming growth factor β1 in the regulation of angiogenesis and endothelial-mesenchymal transition.
    Wang Z; Perez M; Lee ES; Kojima S; Griffin M
    Cell Death Dis; 2017 Sep; 8(9):e3032. PubMed ID: 28880274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
    Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
    J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia and transforming growth factor β1 regulation of long non-coding RNA transcriptomes in human pulmonary fibroblasts.
    Senavirathna LK; Huang C; Pushparaj S; Xu D; Liu L
    Physiol Rep; 2020 Jan; 8(1):e14343. PubMed ID: 31925944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
    Epstein Shochet G; Wollin L; Shitrit D
    Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.